Trulieve Cannabis (TRLV) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 16 99 sessions, June 10, 2026 to October 29, 2026
- Largest daily move
- -12.2% close of September 30, 2026
- 1-month change
- -14.6% closing prices, September 29, 2026 to October 29, 2026
Company Description
Trulieve Cannabis (NYSE: TRLV) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $2.0B.
TRLV has declined 14.6% over the past month. The last closing price was $10.60.
For FY2025, Trulieve Cannabis reported revenue of $1.2B with net income of -$116.4M and diluted earnings per share of -$0.58. The company operates at a net profit margin of -9.8%.
This page collects what Stock Titan holds for TRLV, including price data, latest news, SEC filings, financial highlights, upcoming events, and short interest trends.
Stock Performance
Trulieve Cannabis (TRLV) closed at $10.60 on October 29, 2026. Over the past month, the price has lost 14.6%.
TRLV Metrics & Rankings
Price returns through October 29, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Trulieve Cannabis has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 4 with negative movement. Key topics include conferences, earnings date, earnings. View all TRLV news →
SEC Filings
Trulieve Cannabis has filed 10 recent SEC filings, including 4 Form 8-K, 2 Form 4, 1 Form POSASR, 1 Form 10-Q. The most recent filing was submitted on August 24, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all TRLV SEC filings →
Financial Highlights
Trulieve Cannabis generated $1.2B in revenue in FY2025, retaining a 60.2% gross margin, operating income reached $143.5M (12.2% operating margin), and net income was -$116.4M, reflecting a -9.8% net profit margin. Diluted earnings per share stood at -$0.58. The company generated $272.8M in operating cash flow. The current ratio was 4.43, measuring current assets divided by current liabilities.
Upcoming Events
Q3 2026 Earnings Call
Trulieve Cannabis has 1 upcoming scheduled event. The next event, "Q3 2026 Earnings Call", is scheduled for November 5, 2026 (in 6 days). It is an earnings release or call. Investors can track these dates to stay informed about potential catalysts that may affect the TRLV stock price.
Short Interest History
Short interest in Trulieve Cannabis (TRLV) currently stands at 6.4 million shares, up 25.8% from the previous reporting period, representing 3.9% of the float. Since June 2026, short interest has increased by 2078.2%.
Days to Cover History
Days to cover for Trulieve Cannabis (TRLV) currently stands at 1.9 days, down 34.5% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since June 2026, the figure has increased by 86%. Across the settlements charted above, it has ranged from 1.0 to 2.8 days.
TRLV Company Profile & Sector Positioning
Trulieve Cannabis (TRLV) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the NYSE.